Molecular recognition of fatty acids by peroxisome proliferator- activated receptors

Molecular Cell

Volumn 3, Issue 3, 1999, Pages 397-403

  Xu, H Eric ^a   Lambert, Millard H ^a   Montana, Valerie G ^a   Parks, Derek J ^a   Blanchard, Steven G ^a   Brown, Peter J ^a   Sternbach, Daniel D ^a   Lehmann, Jürgen M ^a   Wisely, G Bruce ^a   Willson, Timothy M ^a   Kliewer, Steven A ^a   Milburn, Michael V ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; FATTY ACID; FIBRIC ACID DERIVATIVE; ICOSAPENTAENOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ARTICLE; CONFORMATION; CRYSTAL STRUCTURE; FATTY ACID DESATURATION; GLUCOSE HOMEOSTASIS; HYDROPHOBICITY; LIGAND BINDING; MOLECULAR RECOGNITION; PROTEIN DOMAIN; RECEPTOR BINDING;

EID: 0033105510     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80467-0     Document Type: Article

References (30)

1. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Moras, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382.
2. Brown, P.J., Smith-Oliver, T.A., Charifson, P.S., Tomkinson, N.C.O., Fivush, A.M., Sternbach, D.D., Wade, L.E., Orband-Miller, L., Parks, D.J., Blanchard, S.G., et al. (1997). Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library. Chem. Biol. 4, 909-91 8.
3. Brünger, A. (1992). X-PLOR Version 3.0: A System for CrystallograPhy and NMR (New Haven, CT: Yale University Press).
4. Brzozowski, A.M., Pike, A.C.W., Dauter, Z., Hubbard, R.E., Bonn, T., Engstrom, O., Ohman, L., Greene, G.L., Gustafsson, J.-A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
5. Catapano, A.L. (1992). Mode of action of fibrates. Pharmacol. Rev. 26, 331-340.
6. Forman, B.M., Chen, J., and Evans, R.M. (1997). Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA 94, 4312-431 7.
7. Göttlicher, M., Widmark, E., Li, Q., and Gustafsson, J.-A. (1992). Fatty acids activate a chimera of the clofibric acid-activated receptor and glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89, 4653-4657.
8. Grundy, S., and Denke, M. (1990). Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 31, 1149-1172.
9. Jungling, E., and Kammermeier, H. (1988). A one-vial method for routine extraction and quantitation of free fatty acids in blood and tissue by HPLC. Anal. Biochem. 171, 150-157.
10. Kliewer, S.A., Forman, B.M., Blumber, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K., and Evans, R.M. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91, 7355-7359.
11. Kliewer, S.A., Sundseth, S.S., Jones, S.A., Brown, P.J., Wisely, G.B., Koble, C.S., Devchand, P., Wahli, W., Willson, T.M., Lenhard, J.M., and Lehmann, J.M. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
12. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M.G., and Wahli, W. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791.
13. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., WillSon, T.M., and Kliewer, S.A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956.
14. Nestel, P.J. (1990). Effects of n-3 fatty acids on lipid metabolism. Annu. Rev. Nutr. 10, 149-16 7.
15. Nichols, J.S., Parks, D.J., Consler, T.G., and Blanchard, S.G. (1998). Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Anal. BioChem. 257, 112-119.
16. Nolte, R., Wisely, G.B., Westin, S., Cobb, J.E., Lambert, M.H., KuroKawa, R., Rosenfeld, M.G., Willson, T.M., Glass, C.K., and Milburn, M.V. (1998). Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137-143.
17. Otwinowski, Z., Isaacs, N., and Burley, S. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend, L. Sawyer, ed. (Daresbury, UK: SERC Daresbury Laboratory), pp. 56-6 2.
18. Rambjor, G.S., Walen, A.I., Windsor, S.L., and Harris, W.S. (1996). Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipid 31, S45-S49.
19. Renaud, J.-P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., and Moras, D. (1995). Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
20. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. (1998). The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82.
21. Schmidt, A., Endo, N., Rutledge, S.J., Vogel, R., Shinar, D., and Rodan, G.A. (1992). Identification of a new member of the steroid receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6, 1634-1641.
22. Schoonjans, K., Martin, G., Staels, B., and Auwerx, J. (1997). Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol. 8, 159-166.
23. Spiegelman, B.M. (1998). Ppar-γ: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507-514.
24. Storlien, L.H., Kriketos, A.D., Calvert, G.D., Baur, L.A., and Jenkins, A.B. (1997). Fatty acids, triglycerides and syndromes of insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids 57, 379-385.
25. Thorpe, J.M. (1963). An experimental approach to the problem of disordered lipid metabolism. J. Antheroscler. Res. 3, 351-360.
26. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D., and Fletterick, R.J. (1995). A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697.
27. Wiberg, K.B., and Murcko, M.A. (1988). Rotational barriers. 2. Energies of alkane rotamers. An examination of gauche interactions. J. Am. Chem. Soc. 110, 8029-8038.
28. Willson, T.M., and Wahli, W. (1997). Peroxisome proliferator-activated receptor agonists. Curr. Opin. Chem. Biol. 1, 235-241.
29. Williams, S.P., and Sigler, P.B. (1998). Atomic structure of progesterone complexed with its receptor. Nature 393, 392-396.
30. Yu, K., Bayona, W., Kallen, C.B., Harding, H.P., Ravera, C.P., McMaHon, G., Brown, M., and Lazar, M.A. (1995). Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975-23983.